Bayhill Therapeutics

Bayhill Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapeutics.

Business Model:

Revenue: $0

Employees: 51-200

Rankings

Detailed Bayhill Therapeutics Information

Geographic Data

Bayhill Therapeutics headquarters map

Address:

City: Portola Valley

State: California

Zip:

Country: United States

Financial Info

Stage:

series unknown

Raised Last:

$10M

Raised Total:

$61M

Metrics

0Website Global Rank

0Website Monthly Traffic

Twitter Followers

Description

Bayhill Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapeutics for autoimmune diseases. The company uses its therapeutic BHT-DNA platform to develop a pipeline of treatment candidates for autoimmune diseases. Its products in clinical pipeline include BHT-3021, which is in Phase I/II clinical trial for reducing or eliminating the immune system’s attack on the pancreas; BHT-3009, which completed its Phase II trial for the treatment of multiple sclerosis; and BHT-3034, which is in preclinical studies for the treatment of myasthenia gravis. The company was formerly known as Tolerion, Inc. and changed its name to Bayhill Therapeutics, Inc. in November 2002. Bayhill Therapeutics, Inc. was founded in 2000 and is headquartered in Palo Alto, California.

Contact Phone:

Contact Email:

Announced Date Company Transaction Money Raised
Announced Date Transaction Number of Investors Money Raised Lead Investors
4/2006 Venture Round 14 $15.8M Quintiles
Boston Life Science Venture
Cathay Venture
CMEA Ventures
DeNovo Ventures
Latterell Venture Partners
Lilly Ventures
Montreux Equity Partners
Morgenthaler Ventures
Pac-Link
Pappas Ventures
Prudence Venture Investment Corporation
The Vertical Group
U.S. Venture Partners
Boston Life Science Venture
Cathay Venture
CMEA Ventures
DeNovo Ventures
Latterell Venture Partners
Lilly Ventures
Montreux Equity Partners
Morgenthaler Ventures
Pac-Link
Pappas Ventures
Prudence Venture Investment Corporation
Quintiles
The Vertical Group
U.S. Venture Partners
7/2009 Venture Round $10M
5/2005 Series B 14 $35.4M Quintiles
Boston Life Science Venture
Cathay Venture
CMEA Ventures
DeNovo Ventures
Latterell Venture Partners
Lilly Ventures
Montreux Equity Partners
Morgenthaler Ventures
Pac-Link
Pappas Ventures
Prudence Venture Investment Corporation
The Vertical Group
U.S. Venture Partners
Boston Life Science Venture
Cathay Venture
CMEA Ventures
DeNovo Ventures
Latterell Venture Partners
Lilly Ventures
Montreux Equity Partners
Morgenthaler Ventures
Pac-Link
Pappas Ventures
Prudence Venture Investment Corporation
Quintiles
The Vertical Group
U.S. Venture Partners
1/2004 Series A 5 - CMEA Ventures
Latterell Venture Partners
Morgenthaler Ventures
The Vertical Group
U.S. Venture Partners
CMEA Ventures
Latterell Venture Partners
Morgenthaler Ventures
The Vertical Group
U.S. Venture Partners
1/2004 Series A 5 - CMEA Ventures
Latterell Venture Partners
Morgenthaler Ventures
The Vertical Group
U.S. Venture Partners
CMEA Ventures
Latterell Venture Partners
Morgenthaler Ventures
The Vertical Group
U.S. Venture Partners
Announced Date Name Price

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research